Today’s Forbes Daily highlights Jeff Bezos’ new AI startup, Recursion fighting tough odds on drug R&D, a reality check on ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

This study investigates the factors responsible for the poor performance of 67 electric utilities in 47 countries, using ...

The ability to respond to changing surroundings was once considered exclusive to complex living organisms. Then came ...

Recursive OS Powered by Symbolic Intelligence Ushers In a New Category of AI Built for Founders, Builders, and Operators Shaping What’s Next ...

Mandated DNS blocking is the wrong tool for public policy enforcement. The DNS exists to make the Internet usable, not to serve as a mechanism of control.

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a ...

Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...